Enhertu (trastuzumab deruxtecan)

pCPA File Number: 23574

Negotiation Status:

Under consideration for negotiation

Indication(s):

Advanced or Metastatic Gastric Cancer or Gastro-esophageal Junction (GEJ) Adenocarcinoma

Sponsor/Manufacturer:

AstraZeneca Canada Inc.

CDA-AMC Project Number:

PC0425-000

pCPA Engagement Letter Issued:

Not Applicable

Negotiation Process Concluded:

Not Applicable